Sun Pharma Advanced Research Company Ltd. - Research Center
532872 SPARC Group (A) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Mar ' 20 |
Sales |
45.13 |
60.00 |
87.39 |
49.86 |
42.31 |
Operating profit |
-193.65 |
-140.80 |
-77.81 |
-108.94 |
-152.07 |
Interest |
0.52 |
4.49 |
4.55 |
8.78 |
1.83 |
Gross profit |
-175.49 |
-145.05 |
-81.80 |
-111.44 |
-150.07 |
EPS (Rs) |
-5.60 |
-5.54 |
-3.20 |
-4.42 |
-5.92 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Mar ' 20 |
Other income |
18.68 |
0.24 |
0.56 |
6.28 |
3.83 |
Stock adjustment |
- |
- |
- |
- |
- |
Raw material |
11.64 |
11.28 |
10.05 |
8.22 |
9.40 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
61.83 |
50.37 |
47.32 |
49.46 |
47.14 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
165.31 |
139.15 |
107.83 |
101.12 |
137.84 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
6.28 |
5.70 |
5.09 |
5.07 |
4.98 |
Taxation |
- |
- |
- |
- |
- |
Net profit / loss |
-181.77 |
-150.75 |
-86.89 |
-116.51 |
-155.05 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
32.45 |
27.19 |
27.19 |
26.35 |
26.21 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
-429.09 |
-234.67 |
-89.04 |
-218.49 |
-359.42 |
GPM (%) |
-275.02 |
-240.79 |
-93.01 |
-198.50 |
-325.25 |
NPM (%) |
-284.86 |
-250.25 |
-98.79 |
-207.53 |
-336.04 |